Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 736 AL 750

Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study

Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH.

Sleep. 2010 Jan;33(1):81-7.

Proteomics in Parkinson's disease: current trends, translational snags and future possibilities

Srivastava G, Singh K, Tiwari MN, Singh MP.

Expert Rev Proteomics. 2010 Feb;7(1):127-39. doi: 10.1586/epr.09.91.

Current concepts in the management of Parkinson disease

Hayes MW, Fung VS, Kimber TE, O'Sullivan JD.

Med J Aust. 2010 Feb 1;192(3):144-9. doi: 10.5694/j.1326-5377.2010.tb03453.x.

The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease

Grealish S, Jönsson ME, Li M, Kirik D, Björklund A, Thompson LH.

Brain. 2010 Feb;133(Pt 2):482-95. doi: 10.1093/brain/awp328. Epub 2010 Jan 31.

Rotigotine adverse effects affecting patient's sexual partner

Hedera P.

Clin Neuropharmacol. 2010 Jan-Feb;33(1):46-7. doi: 10.1097/WNF.0b013e3181b7f292.

Inflammasome signaling at the heart of central nervous system pathology

Chakraborty S, Kaushik DK, Gupta M, Basu A.

J Neurosci Res. 2010 Jun;88(8):1615-31. doi: 10.1002/jnr.22343.

SNPs in CAST are associated with Parkinson disease: a confirmation study

Allen AS, Satten GA.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jun 5;153B(4):973-9. doi: 10.1002/ajmg.b.31061.

Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection

Harkavyi A, Whitton PS.

Br J Pharmacol. 2010 Feb 1;159(3):495-501. doi: 10.1111/j.1476-5381.2009.00486.x. Epub 2010 Jan 29.

Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease

Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM.

Transl Res. 2010 Feb;155(2):62-70. doi: 10.1016/j.trsl.2009.07.006. Epub 2009 Aug 6.

Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease

Björklund T, Carlsson T, Cederfjäll EA, Carta M, Kirik D.

Brain. 2010 Feb;133(Pt 2):496-511. doi: 10.1093/brain/awp314. Epub 2010 Feb 2.

Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia

Valassi E, Klibanski A, Biller BM.

J Clin Endocrinol Metab. 2010 Mar;95(3):1025-33. doi: 10.1210/jc.2009-2095. Epub 2010 Feb 3.

Applying Hsp104 to protein-misfolding disorders

Vashist S, Cushman M, Shorter J.

Biochem Cell Biol. 2010 Feb;88(1):1-13. doi: 10.1139/o09-121.

Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease

Büeler H.

Apoptosis. 2010 Nov;15(11):1336-53. doi: 10.1007/s10495-010-0465-0.

Endoplasmic reticulum stress induced by tunicamycin and antagonistic effect of Tiantai No.1 (1) on mesenchymal stem cells

Wu ZZ, Li YH, Huang AC, Li M, Zhang XL, Wang JG, Yang M, Chen MY.

Chin J Integr Med. 2010 Feb;16(1):41-9. doi: 10.1007/s11655-010-0041-z. Epub 2010 Feb 4.

Background scenery visual hallucinations in a depressed patient with Parkinson's disease

Kataoka H, Inoue M, Ueno S.

Mov Disord. 2010 Apr 30;25(6):786-7. doi: 10.1002/mds.23004.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias